Whitebox Advisors’s ZyVersa Therapeutics ZVSA Stock Holding History

Whitebox Advisors’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-505	Closed	-$1.77M	–	790
2022 Q3	$1.77M	Hold	505	–	–	0.05%	204
2022 Q2	$1.76M	Hold	505	–	–	0.05%	192
2022 Q1	$1.76M	Buy	+505	New	+$1.75M	0.04%	208

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Whitebox Advisors's ZVSA Position: Q4 2022 in Review

Whitebox Advisors sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 505 shares — an estimated $1.77M sold.

Whitebox Advisors first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $1.77M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

Whitebox Advisors reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
Whitebox Advisors sold 505 ZyVersa Therapeutics shares in Q4 2022, an estimated $1.77M.
Whitebox Advisors first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
Whitebox Advisors's ZyVersa Therapeutics position peaked at $1.77M in Q3 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Whitebox Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.